|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -0.21% |
|
-.--% | +3.10% |
| 04-15 | Evotec Taps CureVac Executive as COO | MT |
| 01-06 | CureVac ends coverage after BioNTech acquisition |  |
Chart calendar CureVac
Upcoming events on CureVac
No events available
Past events on CureVac
| 25/11/2025 | Extraordinary General Meeting | 13:00 |
| 25/11/2025 | Présentation aux Actionnaires / Analystes | 13:00 |
| 24/06/2025 | Annual General Meeting | |
| 24/06/2025 | Présentation aux Actionnaires / Analystes | 13:00 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 67,4 73,4 -8.19% | 53,8 66,3 -18.8% | 535 524 2.1% | 0,00 |
|
EBITDA Million EUR | Released Forecast Spread | -226 -190 -19.04% | -251 -185 -35.3% | 196 218 -9.68% | 0,00 |
|
EBIT Million EUR | Released Forecast Spread | -249 -196 -27.26% | -274 -210 -30.42% | 178 192 -7.54% | 0,00 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -249 -205 -21.25% | -260 -186 -39.71% | 190 197 -3.38% | 0,00 |
|
Net income Million EUR | Released Forecast Spread | -249 -199 -24.98% | -260 -199 -30.71% | 162 176 -8.02% | -132 |
|
EPS EUR | Released Forecast Spread | -1,32 -1,04 -26.45% | -1,18 -0,95 -24.78% | 0,72 0,57 26.29% | 0,00 |
| Announcement Date | 25/04/23 | 24/04/24 | 10/04/25 |
Quarterly results
| Fiscal Period | June | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 22,6 29,1 -22.29% | 12,4 12,9 -4% | 14,4 4,91 193.94% | 494 138 257.05% | 14,5 20,6 -29.55% | 0,89 3,34 -73.25% | 1,25 3,34 -62.7% | 54,1 21,4 152.96% |
|
EBITDA Million EUR | Released Forecast Spread | 315 0,02 1655526.32% | |||||||
|
EBIT Million EUR | Released Forecast Spread | -88,0 -36,0 -144.59% | -73,3 -57,4 -27.72% | -73,6 -58,2 -26.6% | 368 341 7.9% | -43,8 5,99 -830.91% | -54,7 -47,3 -15.81% | -61,7 -43,6 -41.64% | 310 0,17 179211.56% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -86,5 -28,0 -208.93% | -69,9 -55,0 -27.07% | -71,2 | 371 128 188.54% | -38,6 24,2 -259.25% | -51,7 -45,5 -13.41% | -60,0 -41,9 -43.29% | 308 -32,0 1060.29% |
|
Net income Million EUR | Released Forecast Spread | -86,7 -25,3 -242.5% | -70,6 -48,8 -44.72% | -72,5 -53,0 -36.87% | 338 328 3.11% | -32,8 6,86 -577.62% | -52,1 -41,1 -26.63% | -59,6 -38,9 -52.98% | 273 -33,3 920.51% |
|
EPS EUR | Released Forecast Spread | -0,39 -0,18 -112.38% | -0,31 -0,24 -29.16% | -0,32 -0,30 -6.26% | 1,50 0,42 254.72% | -0,14 -0,19 26.55% | -0,23 -0,18 -25.82% | -0,26 -0,18 -43% | 1,21 -0,15 889.15% |
| Announcement Date | 24/04/24 | 23/05/24 | 15/08/24 | 12/11/24 | 10/04/25 | 20/05/25 | 15/08/25 | 24/11/25 |
Past sector events for CureVac
- Stock Market
- Stocks
- CVAC Stock
- Calendar CureVac
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition